Merck touts a 60% price cut, but the drug is outdated and on the way out
July 20, 2018 at 15:55 PM EDT
The hepatitis C drug’s sales have declined since newer, better treatments hit the market.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|